For the quarter ending 2026-03-31, NEO made $186,672K in revenue. -$17,106K in net income. Net profit margin of -9.16%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net revenue | 186,672 | 173,642* | 187,797 | 181,330 |
| Cost of revenue | 105,808 | 95,905* | 107,351 | 104,072 |
| Gross profit | 80,864 | 77,737* | 80,446 | 77,258 |
| Restructuring charges | - | - | 0 | 0 |
| General and administrative | 65,741 | 41,029* | 69,874 | 71,747 |
| Research and development | 9,534 | 10,502* | 8,694 | 9,023 |
| Sales and marketing | 23,830 | 23,186* | 21,806 | 24,075 |
| Restructuring charges | - | 0* | - | - |
| Impairment charges (note 5) | - | - | 7,086 | 20,041 |
| Impairment charges (note 3 and note 7) | - | 6,938* | - | - |
| Total operating expenses | 99,105 | 81,654* | 107,460 | 124,886 |
| Loss from operations | -18,241 | -3,917* | -27,014 | -47,628 |
| Interest income | 1,273 | 3,331* | 1,563 | 2,263 |
| Interest expense | 598 | 1,449* | 603 | 933 |
| Other expense (income), net | -12 | 76* | -335 | 482 |
| Loss before taxes | -17,578 | -1,960* | -26,389 | -45,816 |
| Income tax (benefit) expense | -472 | -2,267* | 740 | -724 |
| Net gain | -17,106 | 307 | -27,129 | -45,092 |
| Basic Average Shares | 129,166,000 | 127,939,000 | 128,415,000 | 127,949,000 |
| Diluted Average Shares | 129,166,000 | 127,939,000 | 128,415,000 | 127,949,000 |
NEOGENOMICS INC (NEO)
NEOGENOMICS INC (NEO)